PSEN1 and Alzheimer disease: In line with the concept that aerobic glycolysis is beneficial or protective, and OxPhos is not, hiPSC-derived astrocytes from AD patients harboring the PSEN1 ΔE9 mutation are more oxidative than isogenic controls, with increased ROS production and decreased lactate secretion (Oksanen et al., 2017).